<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="1258">
  <stage>Registered</stage>
  <submitdate>3/05/2006</submitdate>
  <approvaldate>29/05/2006</approvaldate>
  <actrnumber>ACTRN12606000203550</actrnumber>
  <trial_identification>
    <studytitle>Long-term health effects of high and low carbohydrate diets in obese subjects 
with the metabolic syndrome</studytitle>
    <scientifictitle>Long-term health effects of high and low carbohydrate, weight loss diets in obese subjects with the metabolic syndrome</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Obesity</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>participants will be randomised for the 52 week intervention duration to either;
1. Low carbohydrate diet:35% protein,
61% fat (20% saturated fat)
4% carbohydrate

2. High carbohydrate,low fat diet:18% protein, 27% fat (&lt;8% saturated fat)
55% carbohydrate</interventions>
    <comparator>1. Low carbohydrate diet:35% protein,
61% fat (20% saturated fat)
4% carbohydrate</comparator>
    <control>Active</control>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Weight loss</outcome>
      <timepoint>At 8 weeks and 52 weeks after start of diet intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Lipids, insulin, glucose, blood pressure, body composition, flow mediated dilatation, physical function, psychological health, bone health &amp; renal function and nutrition adequacy.</outcome>
      <timepoint>At 8 and 52 weeks after start of diet intervention.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>High waist circumferenceat least one cardiovascular risk factor.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Have proteinuria, a malignancy, or a history of metabolic disease such as liver, kidney, cardiovascular, respiratory or gastrointestinal disease, diabetes (fasting blood glucose or are pregnantUncontrolled hypertension (resting recumbent BP &gt;160/110 mmHg).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>allocation is not concealed</concealment>
    <sequence>random allocation using computer software clinstat</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>two dietary patterns</designfeatures>
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>3/04/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up continuing</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>national health &amp; medical research council of Australia</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>national heart foundation of Australia</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>national health &amp; medical research council of Australia</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Charities/Societies/Foundations</sponsortype>
      <sponsorname>national heart foundation</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Obesity is a major health problem, which contributes to significant morbidity and mortality in Australia. Energy restriction and exercise are commonly advocated as lifestyle approaches for the modification of cardiovascular disease risk factors such as obesity, hyperlipidemia, impaired glucose tolerance, and insulin resistance. In response to the increasing concerns about the rising level of obesity, there has been a multitude of fad diets developed outside the medical and nutritional recommendations for healthy eating and with this an increased popularity of diets very low in carbohydrates. However, due to the scant scientific evidence available for the long-term efficacy and safety of these diets, and their impact on risk factors for cardiovascular disease, cancer, renal function, bone health, psychosocial function and the capacity to undertake concurrent physical activity, there is a lack of evidenced-based public health recommendations and policy regarding these dietary patterns. This study will provide scientific evidence to validate optimum dietary recommendations for weight loss that can be used by health professionals who have a strong need for a rational basis for their advice to counsel obese patients.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CSIRO Human Nutrition</ethicname>
      <ethicaddress>Adelaide, South Australia</ethicaddress>
      <ethicapprovaldate />
      <hrec> 05/31</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Grant Brinkworth</name>
      <address>CSIRO Human Nutrition
PO Box 10041
Adelaide BC SA 5000</address>
      <phone>+61 8 83038830</phone>
      <fax>+61 8 8303 8899</fax>
      <email>grant.brinkworth@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Grant Brinkworth</name>
      <address>CSIRO Human Nutrition
PO Box 10041
Adelaide BC SA 5000</address>
      <phone>+61 8 83038830</phone>
      <fax>+61 8 8303 8899</fax>
      <email>grant.brinkworth@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>